Metabolic differences and their impact on human disease: Sulfotransferase and colorectal cancer

Environmental Toxicology and Pharmacology

Volumn 4, Issue 3-4, 1997, Pages 277-281

  Frame, Lynn T ^a   Gatlin, Tracy L ^a   Kadlubar, Fred F ^b   Lang, Nicholas P ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

African American; Colon cancer; Colorectal cancer; Interindividual variability; Molecular epidemiology; Sulfotransferase

Indexed keywords

CARCINOGEN; SULFOTRANSFERASE;

ACETYLATION; CANCER RISK; CASE CONTROL STUDY; COLON CANCER; COLORECTAL CANCER; CONFERENCE PAPER; GENETIC POLYMORPHISM; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TOXICOLOGY;

EID: 0031444566     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(97)10023-0     Document Type: Conference Paper

References (18)

1. Chou H.-C., Lang N.P., Kadlubar F.F. Metabolic activation of N-hydroxyarylamines and N-hydroxyheterocyclic amines by human sulfotransferase(s). Cancer Res. 55:1995;525.
2. Coughlin S.S., Benichou J., Weed D.L. Attributable risk estimation in case-control studies. Epidemiol. Rev. 16:1994;51.
3. Falany C.N. Molecular enzymology of human liver cytosolic sulfotransferases. Trends Pharmacol. Sci. 12:1991;255.
4. 32P-postlabelling. Chem. Res. Toxicol. 7:1994;733.
5. Kaderlik K.R., Mulder G.J., Shaddock J.G., Casciano D.A., Teitel C.H., Kadlubar F.F. Effect of glutathione depletion and inhibition of glucuronidation and sulfation on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism, PhIP-DNA adduct formation and unscheduled DNA synthesis in primary rat hepatocytes. Carcinogenesis. 15:1994;1711.
6. Kaderlik K.R., Mulder G.J., Turesky R.J. et al. Glucuronidation of N-hydroxyheterocyclic amines by human and rat liver microsomes. Carcinogenesis. 15:1994;1695.
7. Huber W., Hammons G., McDaniel P., Kaderlick K., Teitel C., Lang C., Kadlubar F. Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutat. Res. 376:1997;115.
8. Lang N.P., Butler M.A., Massengill J. et al. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prev. 3:1994;675.
9. Lin D., Meyer D.J., Ketterer B., Lang N.P., Kadlubar F.F. Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. Cancer Res. 54:1994;4920.
10. Lin, D.-X., Kadrelik, K.R., Turesky, R.J., Miller, D.W., Lay, Jr., J.O., Kadlubar, F.F., 1992. Identification of N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine as the major adduct formed by the food borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, with DNA. Chem. Res. Toxicol. 5, 691.
11. Malfatti M.A., Connors M.S., Mauthe R.J., Felton J.S. The capability of rat colon tissue slices to metabolize the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res. 56:1996;2550.
12. Marazziti D., Palego L., Mazzanti C., Silvestri S., Cassano G.B. Human platelet sulfotransferase shows seasonal rhythms. Chronobiol. Int. 12:1995;100.
13. Mulder G.J., Hinson J.A., Gillette J.R. Generation of reactive metabolites of N-hydroxyphenacetin by glucuronidation and sulfation. Biochem. Pharmacol. 26:1977;189.
14. Ozawa S., Chou H.-C., Kadlubar F.F., Nagata K., Yamazoe Y., Kato R. Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b] pyridine by cDNA-expressed human and rat arylsulfotransferases. Jpn. J. Cancer Res. 85:1994;1220.
15. Price R.A., Spielman R.S., Lucena A.L., van Loon J.A., Maidak B.L., Weinshilboum R.M. Genetic polymorphism for human platelet thermostable phenol sulfotransferase (TS PST) activity. Genetics. 122:1989;905.
16. Redman, B.G., Kawachi, M., Schwartz, D., 1996. Urothelial and kidney cancers. In: Pazdur, R., Coia, L.R., Hoskins, W.J., Wagman, L.D. (Eds.), Cancer Management: A Multidisciplinary Approach. PRR, Inc. Huntington, NY, p. 417.
17. Sundaram R.S., van Loon J.A., Tucker R., Weinshilboum R.M. Sulfation pharmacogenetics: correlation of human platelet and small intestinal phenol sulfotransferase. Clin. Pharmacol. Ther. 46:1989;501.
18. Weinshilboum R., Aksoy I. Sulfation pharmacogenetics in humans. Chem.-Biol. Interact. 92:1994;233.